Acute Pancreatitis in a Patient With COVID-19 After the Resolution of Respiratory Symptoms
Author(s) -
Hafiz Muhammad Jeelani,
Muhammad Mubbashir Sheikh,
Shirly Samuel,
Yetunde B Omotosho,
Artem Sharko,
Rami Albetar
Publication year - 2021
Publication title -
journal of investigative medicine high impact case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.247
H-Index - 10
ISSN - 2324-7096
DOI - 10.1177/23247096211024773
Subject(s) - medicine , pancreatitis , tmprss2 , covid-19 , respiratory system , acute pancreatitis , epigastric pain , gastroenterology , pathogenesis , intensive care medicine , disease , infectious disease (medical specialty) , vomiting
The gastrointestinal (GI) involvement, including acute pancreatitis (AP) from the novel coronavirus disease-2019 (COVID-19), is increasingly being reported. Recent evidence suggests that the pathogenesis of COVID-19 is mediated by the angiotensin-converting enzyme 2 (ACE-2) receptors and transmembrane protease serine 2 (TMPRSS2) for “priming,” which is highly expressed in the pancreas. To our knowledge, there is no other reported case of AP associated with COVID-19 after the respiratory symptoms are resolved. In this article, we present a patient with COVID-19, who came with intractable epigastric pain and resolved respiratory symptoms. A diagnosis of AP complicated with COVID-19 was made after laboratory and imaging workup, which was successfully managed conservatively.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom